-
Jasmine coffee or poison? This exotic Chinese drink may trigger severe liver damage
29 Dec 2025 21:44 GMT
What began as a seemingly harmless habit, 2 to 3 cups of an 'exotic' jasmine-flavoured instant coffee, ended in severe hepatitis, jaundice and intense itching for a patient. After a whodunit-style medical investigation, doctors traced the liver …
-
China approves Innovent’s ipilimumab for colon cancer
29 Dec 2025 20:01 GMT
China’s National Medical Products Administration approved Innovent Biologics Inc.’s NDA for Tabosun (ipilimumab N01, IBI-310) in combination with sintilimab as neoadjuvant treatment for stage IIB-III resectable microsatellite instability-high or mismatch …
-
ASK Pharm makes China rights deal; Unicycive resubmits kidney drug after CRL
29 Dec 2025 19:17 GMT
-
Multi-Target Therapeutic Effects of YuPingTongQiao (YPTQ) in Allergic Rhinitis: A Traditional Chinese Medicine Restoring Dysregulated TFR Cells and Reinforcing Epithelial Barrier Integrity
29 Dec 2025 19:16 GMT
… Center of Ren Ji Hospital (Shanghai, China). The sample size was determined … A2101001), were obtained from Beijing Yiling Pharmaceutical Co., Ltd. The commercially … ; YPTQ, YuPingTongQiao; TCM, Traditional Chinese Medicine; CRS, Chronic rhinosinusitis; ECRS …
-
Electroacupuncture as a Non-Pharmacological Intervention for Nicotine Dependence: Evidence from a Randomized Clinical Trial
29 Dec 2025 19:15 GMT
… Yueyang Hospital, Shanghai University of Traditional Chinese Medicine, were … The registration number of China Clinical Trial Registry is … for Nicotine Replacement Therapy. Beijing: People’s Medical … group randomised trials. J Pharmacol Pharmacother. 2010;1(2): …
-
Lupin inks licensing pact with Chinese firm for obesity drug
29 Dec 2025 19:06 GMT
… affected by the condition. Drug maker Lupin on Monday said … pact with China-based Gan & Lee Pharmaceuticals for a … diabetes.
The Mumbai-based drug maker said the agreement strengthens … showcasing the value of Chinese biopharmaceutical innovation on the …
-
Pharmaceutical Regulatory Affairs in Asia Training Course: Important Aspects of Gaining and Maintaining a Successful Marketing Authorisation (Mar 24th - Mar 26th, 2026) - ResearchAndMarkets.com
29 Dec 2025 18:22 GMT
… is primarily designed for Pharmaceutical Regulatory Affairs professionals:
Those … Philippines
Brunei
PR of China
Day 2
India
Malaysia … VIET NAM INDONESIA INDIA CHINA HONG KONG SOUTH KOREA … SINGAPORE
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and …
-
Novo Nordisk Halves Wegovy Prices In China Ahead Of Generic Threat
29 Dec 2025 16:35 GMT
… about 50% in parts of China, signaling a defensive move … com’s (NASDAQ:JD) online pharmacy have also been lowered, allowing … Novo’s semaglutide patent in China expires in March, opening … pressure has already increased following China’s approval of a …
-
Lupin signs exclusive licensing agreement with Gan & Lee Pharmaceuticals for novel GLP-1 receptor agonist
29 Dec 2025 15:06 GMT
… Gan & Lee Pharmaceuticals, headquartered in China, for a novel fortnightly … showcasing the value of Chinese biopharmaceutical innovation on the … Bulls
Keywords
Lupin
INE326A01037
Pharmaceuticals
LicensingAgreement
GanandLeePharmaceuticals
GLP1
Receptor
-
Lupin signs agreement with Gan & Lee Pharma for novel GLP-1 receptor agonist
29 Dec 2025 14:54 GMT
… agreement with Gan & Lee Pharma for novel GLP-1 receptor … India
image credit- shutterstock
Indian pharma major Lupin Limited has entered … with Gan & Lee Pharmaceuticals, headquartered in China, for a novel fortnightly …
About
© 1995-2025